A dual‑center study evaluates the systemic inflammation–nutrition index (SINI) as a predictor of pathological response and prognosis in locally advanced #GIST treated with neoadjuvant imatinib. A SINI‑based nomogram showed strong discrimination.
buff.ly/pvg142X
#Sarcoma #Imatinib #Biomarkers

Häufige Arzneistoffe: Steckbrief Imatinib Aus der Onkologie sind Tyrosinkinase-Hemmer heute nicht mehr wegzudenken. Der erste Vertreter war vor knapp 25 Jahren Imatinib. Der Wirkstoff war auch der ...

Unter anderem aus der #Onkologie sind #Tyrosinkinase-Hemmer heute nicht mehr wegzudenken. Der erste Vertreter war vor knapp 25 Jahren #Imatinib – übrigens auch der erste Wirkstoff, der mit dem PZ-Innovationspreis ausgezeichnet wurde.

How to Find Reliable Suppliers for Imatinib 400 mg in Philippines Introduction to Imatinib 400 mgImatinib 400 mg serves as a common treatment for specific cancer types which include chronic myeloid leukemia and gastrointestinal stromal tumors. The mechanism of Imati...

How to Find Reliable Suppliers for Imatinib 400 mg in Philippines

Healthcare providers and patients rely on dependable Imatinib 400 mg suppliers throughout the Philippines to obtain effective cancer treatments.

Learn More: oddwaypharmacy.wixsite.com/oddwaypharma...

#Imatinib #Leukemia #Health

Decreased M6A Modification Promotes Progression of Gastrointestinal Stromal Tumor and KIT‐Derived Imatinib Resistance Through FTO‐Regulated Axis The study identifies decreased m6A levels, FTO and lncRNA XIST as critical oncogenic molecules in gastrointestinal stromal tumor (GIST) progression and imatinib resistance, both in vitro and in vivo....

#Article in #MedComm_Oncology
Decreased M6A Modification Promotes Progression of Gastrointestinal Stromal Tumor and KIT-Derived #Imatinib Resistance Through FTO-Regulated Axis doi.org/10.1002/mog2...

#GIST #XIST #KIT #DrugResistance #N6_methyladenosine #FTO #lncRNA

The emerging role of Imatinib in malaria management: a review of evidence and future directions Imatinib, a selective tyrosine kinase inhibitor primarily used to treat CML and GI tumors, has emerged as a potential adjunctive therapeutic for malaria. Explore its pharmacokinetics, its use in…

#Imatinib, a TKI primarily used to treat CML and GI tumors, has emerged as a potential adjunctive therapeutic for #malaria.

Explore its pharmacokinetics, its use in at-risk populations, and the advantages and challenges to its repurposing.

👉 buff.ly/WGHikMH

#IDSky #MedSky

a doctor says " trust me i 'm a doctor " in a hospital ALT: a doctor says " trust me i 'm a doctor " in a hospital

#Doctors appoint was earlier. More bloodwork checking how the #imatinib 's working. Gotta see a #hematologist about new #hereditarycondition (HAE type 2). Doc's gonna start me on emergency injectables, then the dailies. She did reading & my condition is both rare & complex. I could have guessed.

How to define or prove disease modification - catch up on ‪@mark-toshner.bsky.social‬ thought-provoking talk from #DDDS2025 🎥
pvrinstitute.org/learning-hub...
#PAH #BMP #Imatinib #Sotatercept #DiseaseModification

a man wearing a mask with the words " life is pain " below him ALT: a man wearing a mask with the words " life is pain " below him

Ugh, things are gonna be rough in while. Been on #imatinib 5 days. I up my dose Sunday along with taking my shot. My blood work is all over the place. Have to set an appointment soon to check up.

Stupid pharmacy is fucking up my meds. I might run out soon.👿

Being #chronicallyill is so fun! 🤬

It feels final now.

Got my #imatinib today, & they came in this bag. I start with half a pill for 7 days, then start upping the dose. Going to get weekly blood draws from here on out.💉

Wish me luck. I'm scared of how my body will react. 💊

#ChronicIllness #disabled #medication #chemotherapy

Small Trials, Big Impact: How Innovative Design Revived Imatinib and Offers a Blueprint for Lean Biotech For small biotech companies, the journey of drug development is often a high-stakes, tightrope walk, balancing scarce resources against the immense challenge of bringing novel therapies to patients.

Small Trials, Big Impact: How Innovative Design Revived Imatinib and Offers a Blueprint for Lean Biotech open.substack.com/pub/drugdeve...

#FDA. #CLINICALTRIAL #IMATINIB #INNoVATION #DRUGDEVELOPMENT

Researchers link 9 blood proteins to breast cancer and suggest 3 drugs for repurposing Researchers used integrated Mendelian randomization in a cohort of over 247,000 individuals to identify 62 plasma proteins associated with breast cancer risk. Nine high-confidence targets, including U...

Researchers link 9 blood proteins to breast cancer and suggest 3 drugs for repurposing 🧬💊🧪 www.news-medical.net/news/2025041... #BreastCancer #PlasmaProteins #DrugDiscovery #Imatinib #Biomarkers #Oncology #CancerGenomics @commsbio.bsky.social

Body mass index affects imatinib exposure: Real‐world evidence from TDM with adaptive dosing Background Imatinib is the treatment of elderly or frail patients with chronic myeloid leukemia (CML). Trough levels of around 1000 ng/ml are considered as the target exposure. Objectives We searc...

Now available in Open Access:
Body mass index affects imatinib exposure: Real-world evidence from TDM with adaptive dosing
onlinelibrary.wiley.com/doi/full/10....

#pharmacology #imatinib #pharmacokinetics #bodymassindex

SARS-CoV-2 infection causes dopaminergic neuron senescence COVID-19 patients commonly present with signs of central nervous system and/or peripheral nervous system dysfunction. Here, we show that midbrain dopamine (DA) neurons derived from human pluripotent s...

#SARSCoV2 infection causes dopaminergic neuron senescence #LongCovid #riluzole #metformin #imatinib

pmc.ncbi.nlm.nih.gov/articles/PMC...

FDA Approves Shorla Oncology’s Imkeldi: A Game-Changer in Cancer Treatment Shorla Oncology has achieved a significant milestone with the U.S.

www.linkedin.com/pulse/fda-ap...

FDA Approves Shorla Oncology’s Imkeldi: A Game-Changer in Cancer Treatment

#ShorlaOncology #Imkeldi #FDAApproval #CancerTreatment #CML #ALL #Imatinib #OncologyInnovation #PatientCare #HealthcareAdvancements #Humanteconomy #Humantec #KStrategyand